Where does Laurus Labs Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Laurus Labs Limited ranks #6,167 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Laurus Labs Limited hold?

Laurus Labs Limited holds 55 US utility patents granted between 2015 and 2024, spanning 9 technology areas.

What is Laurus Labs Limited's Innovation Score?

Laurus Labs Limited has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Laurus Labs Limited focus on?

Laurus Labs Limited's top technology area is C07D (Heterocyclic Compounds) with 47 patents, ranking #168 of 3,165 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Laurus Labs Limited's patent grant rate increasing or decreasing?

Laurus Labs Limited's recent grant velocity is +12% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Laurus Labs Limited's patents?

Laurus Labs Limited's patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Laurus Labs Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Laurus Labs Limited

USPTO PatentsView assignee record - 55 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Laurus ranks #6,167 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 9 technology areas.

#6,167
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 17.9
avg claims per patent: +12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6167 · Foreign Corporation #6,167 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,167/49,997
PHOTO-FINISH Keiper & KG
CPC-NARROW C07D · 9 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 17.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +12% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Keiper GMBH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Laurus’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (36%) Velocity 3.2 pts (8%) Breadth 10.6 pts (28%) Claim depth 10.7 pts (28%)

Qualcomm Incorporated · highest

85
Adaptimmune · near

38
BAE Systems Imaging… · near

38
Laurus Labs · this assignee

38
Orion · near

38
Tokyo Women's… · near

38
3D Lighting… · lowest

7

What this shows Laurus's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Laurus?

Each dot is one of Laurus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Laurus’s own 17.9 claims/patent is ABOVE the 12.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Laurus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Laurus's grants concentrate

Laurus Labs Limited is a focused PatentsView assignee: 9 CPC subclasses with 85.5% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2020 (14 grants) versus a trough of 1 in 2023. By volume, Laurus sits between Keiper GMBH & Co. KG and Medicrea International.

Laurus's three-year grant acceleration

From 2019–2021 to 2022–2024, Laurus Labs Limited moved from 23 to 11 grants (0.48x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Keiper & KG

55
Korea University…

55
Kwikspace Guam

55
Lanto

55
Liebherr-werk Nen…

55
MAG Aerospace Ind…

55
MAN Truck & Bus SE

55
Medicrea Internat…

55
Laurus Labs ◀

55

What this shows Laurus holds 55 patents at rank #6,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Laurus

By rank, the assignees closest to #6,166 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Laurus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Laurus, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Laurus ranks #168 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Orion Corporation 38 BAE Systems Imaging Solutions Inc. 38 Tokyo Women's Medical University 38 Adaptimmune Limited 38

Similar claim depth

Nearest assignees by average claims per patent (17.9 here).

Autobrains Technologies Ltd 17.9 avg Sartorius Stedim North America Inc. 17.9 avg Cigna Intellectual Property, Inc. 17.9 avg Inguran, LLC 17.9 avg

Laurus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Laurus Labs Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	12.7%
2016	4	7.3%
2017	5	9.1%
2018	5	9.1%
2019	5	9.1%
2020	14	25.5%
2021	4	7.3%
2022	8	14.5%
2023	1	1.8%
2024	2	3.6%

Which technologies does Laurus Labs Limited patent most?

C07D - Heterocyclic Compounds 47

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 28

C07C - Acyclic OR Carbocyclic Compounds 26

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 19

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 17

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

C07K - Peptides 4

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Laurus Labs Limited's patent record in context - here's where to go next.

Laurus Labs Limited's lead technology class is C07D (Heterocyclic Compounds), 85.5% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #6,167 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Laurus Labs Limited against Keiper GMBH & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.